ARTEMISIA TRIDENTATA POLLEN: 16 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
16
Total FAERS Reports
0
Deaths Reported
1
Hospitalizations
16
As Primary/Secondary Suspect
1
Life-Threatening
ALK-Abello, Inc.
Manufacturer
Drug Class: Allergens [CS] · Manufacturer: ALK-Abello, Inc. ·
First Report: 20131023 · Latest Report: 20250604
What Are the Most Common ARTEMISIA TRIDENTATA POLLEN Side Effects?
#1 Most Reported
Injection site urticaria
3 reports (18.8%)
#2 Most Reported
Injection site swelling
3 reports (18.8%)
#3 Most Reported
Injection site reaction
3 reports (18.8%)
All ARTEMISIA TRIDENTATA POLLEN Side Effects by Frequency
No side effect data available.
Who Reports ARTEMISIA TRIDENTATA POLLEN Side Effects? Age & Gender Data
Gender: 75.0% female, 25.0% male. Average age: 26.9 years. Most reports from: US. View detailed demographics →
Is ARTEMISIA TRIDENTATA POLLEN Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2013 | 1 | 0 | 0 |
| 2015 | 1 | 0 | 0 |
| 2016 | 3 | 0 | 0 |
| 2019 | 1 | 0 | 0 |
| 2020 | 1 | 0 | 0 |
| 2022 | 3 | 0 | 0 |
| 2024 | 1 | 0 | 0 |
| 2025 | 1 | 0 | 0 |
What Is ARTEMISIA TRIDENTATA POLLEN Used For?
| Indication | Reports |
|---|---|
| Product used for unknown indication | 6 |
Other Drugs in Same Class: Allergens [CS]
Official FDA Label for ARTEMISIA TRIDENTATA POLLEN
Official prescribing information from the FDA-approved drug label.